[ad_1]
The Measles Initiative was established in 2001 to form a global partnership to coordinate efforts to prevent child mortality and morbidity from the highly contagious measles virus. In the year In 2012, the founding partners – the American Red Cross, the US Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF, and the World Health Organization (WHO) – agreed to incorporate measles under a new name, the Measles and Rubella Initiative. (M&RI)
Huge strides have been made since then. The Initiative has helped bring measles vaccines to children worldwide, saving more than 56 million lives worldwide since its inception and investing more than $1.2 billion in measles and rubella control efforts in partnership with GAVI, the Vaccine Alliance, and the Bill & Melinda Gates Foundation (BMGF). ).
The impact of these investments is high. In the year From 2000 to 2021, the annual number of measles deaths decreased by 83 percent, from 761,000 to 128,000. Although much progress has been made, the goal is to work with countries and partners to achieve the goals of the Immunization Agenda 2030 (IA2030). In the year To save another 50 million people by the end of 2030 with access to essential vaccines, the measles vaccine will account for the largest share.
M&RI then launched a consultation process to fully integrate its strategy, coordination and action with the IA2030 strategy and partnership processes. As a result of that process, the newly revamped M&RI partnership is now called IA2030. Measles and measles partnership (M&RP) The transition started on 1 January 2023 and is now formalized.
Working together in previous years, the membership of the IA2030 M&RP included the original five founders and expanded to include Gavi and BMGF as core partners.
The transition comes at a time when the world has seen its worst decline in global immunization coverage in 30 years, largely due to the Covid-19 pandemic and related disruptions. It is appropriate because we need to work closer than ever to address the nearly 40 percent number of unvaccinated children worldwide.
IA2030 is in its early years, and we are among the first initiatives to transition to IA2030 governance. We hope that our success will serve as an example for other disease-specific initiatives in the years to come. This transition
best regard
Bill and Melinda Gates Foundation
US Centers for Disease Control
About Measles and Measles Partnership (M&RP) and Immunization Agenda 2030 (IA2030)
of Measles and measles partnership (M&RP), formerly the Measles and Rubella Initiative, has been helping to deliver measles and rubella vaccines to children worldwide since 2000, saving more than 56 million lives and significantly reducing birth defects due to congenital measles. Despite this progress, measles remains the leading vaccine-preventable killer of children worldwide. Under the umbrella Immunization Agenda 2030 (IA2030) and directed by Measles and Measles Strategic Framework 2030 (MRSF), M&RP’s current mission includes addressing the decline in national immunization coverage, accelerating recovery from the COVID-19 pandemic, and making progress toward a measles- and rubella-free world. The partnership consists of American Red Cross, Bill and Melinda Gates Foundation, Gavi, vaccine combination, US CDC, United Nations, UNICEF And World Health Organization.
M&RP is part of that. IA2030A global strategy aimed at maximizing the life-saving impact of vaccines – one of the most successful and cost-effective public health interventions of all time. IA2030 aims to prevent more than 50 million deaths by 2030 by obtaining essential vaccines and building healthcare systems to cope with the impact of epidemics and rapid vaccine response.
For more information about the Measles and Rubella Partnership, please visit the Measles and Rubella Partnership website
|
Sources 2/ https://www.who.int/news/item/22-02-2023-a-new-era-in-the-fight-against-measles-and-rubella The mention sources can contact us to remove/changing this article |
[ad_2]